Andrew Mandlsohn is an associate in Smart & Biggar's Toronto office. Andrew's practice focuses exclusively in the life sciences arena where he assists companies in navigating and overcoming complex legal and regulatory challenges. With a client-centric approach and a deep knowledge and understanding of the pharmaceutical industry, Andrew advises and advocates on behalf of innovative companies in litigation in the Ontario and Federal Courts, including under the Patented Medicines (Notice of Compliance) Regulations (patent validity, infringement and damages quantification). Andrew also provides strategic advice to life sciences companies on a variety of issues impacting their businesses, including regulatory compliance (under the Food and Drugs Act and associated regulations), pricing and reimbursement (such as matters within the jurisdiction of the Patented Medicine Prices Review Board and under applicable provincial legislation) and requests for disclosure made under federal and provincial acts.
Prior to joining Smart & Biggar, Andrew worked at a U.S. State Department of Public Health (Division of Food and Drug), hospital, retail community and specialty pharmacies, a leading American biopharmaceutical company (Division of Regulatory Strategy and Intelligence), and a leading national law firm where he specialized in pharmaceutical litigation (patents and product liability). Through these experiences, and as a lawyer and pharmacist licenced to practice in both Canada and the U.S., Andrew has acquired significant knowledge of the laws governing the life science and healthcare industries, as well as expertise in pharmacy practice (including pharmacotherapy, drug interchangeability and reimbursement).
While pursuing his pharmacy degree at the Massachusetts College of Pharmacy, Andrew was elected to The Rho Chi Society (the academic honour society in pharmacy). Upon graduation he was recognized for his high academic achievement and outstanding communication skills with an Award of Excellence. Andrew attended Suffolk University Law School where he attained the highest standing in his Health Law course and obtained a Concentration Certificate in Health and Biomedical Law.
Andrew is an associate of the Intellectual Property Institute of Canada, and a member of The Advocates' Society, the Toronto Intellectual Property Group, the Canadian Association of Professionals in Regulatory Affairs and the Ontario Bar Association (Civil Litigation and Intellectual Property sections).
Since 2015, Andrew has been recognized annually as a 'Rising Star' in Life Sciences.
He was called to the Massachusetts Bar in 2003 and the Ontario Bar in 2006.